Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen, Oxford Gene Technology

Premium
Asuragen has introduced its RNARetain pre-analytical RNA stabilization solution in Europe after receiving regulatory approval for the product.
 
According to the company, the solution is a clinically validated and cGMP-manufactured sample collection and RNA stabilization solution. It is labeled for the collection, storage, and transport of clinical human cellular and solid tissue specimens, as well as the stabilization of intracellular RNA within these specimens for subsequent extraction and molecular analysis, according to Asuragen.
 

 
Oxford Gene Technology has launched a new microRNA-profiling service.
 
According to the company, the service offers high-quality, customizable microarrays with the most up-to-date miRNA probe sequences, providing data from samples in days.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.